DC Chemicals

All products / DC10820

Roquinimex(Linomide)
CAT. NO. DC10820

Roquinimex(Linomide)

Pack sizes and prices

Pack sizePrice
100 mg$350 USDRequest a quote / confirm availability →
250 mg$600 USDRequest a quote / confirm availability →
1 g$1,350 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

Roquinimex (Linomide; PNU212616; ABR212616) is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity; inhibits angiogenesis and reduces the secretion of TNF alpha.IC50 value:Target: TNF alphaProphylactic administration of DSS-treated mice with roquinimex significantly reduced clinical signs of colitis, MDS and the CH-reduction. Moreover, in roquinimex treated animals, the MPO activity was significantly reduced by more than 50% compared to DSS control mice. Notably, therapeutic administration of roquinimex in DSS-treated mice also significantly inhibited the MDS, CH-reduction and MPO activity [2]. Linomide, a synthetic immunomodulator, at concentrations effective in vivo reduces the number of MBP-reactive TNF-alpha and increases MBP-reactive IL-10 and TGF-beta mRNA expressing MNC from MS patients' blood when analysed in vitro. Compared to dexamethasone, Linomide up-regulated levels of blood MNC expressing mRNA of TGF-beta after culture in presence of MBP [3].

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC10820
Product nameRoquinimex(Linomide)
CAS84088-42-6
Molecular formulaC18H16N2O3
Molecular weight308.33124
Purity>98%
SMILESCN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — Roquinimex(Linomide) (DC10820)

Related research products

Browse newly added products